Background: Preterm infants frequently suffer from cardiovascular compromise due to tissue hypoxia, leading to hypotension and/or low systemic blood flow. Many preterm infants respond inadequately to inotropic treatments using adrenergic agonists such as dobutamine or dopamine. This may be due to altered quantity or type of cardiac adrenoceptor expression due to tissue hypoxia-ischaemia (HI), or prolonged exposure to adrenergic agonists. We measured the effects of severe HI and dobutamine/dopamine treatment on cardiac adrenoreceptors in preterm fetal sheep.
EVALUATING THE COMBINATION OF BOVINE LACTOFERRIN AND BIFIDOBACTERIUM BREVE M-16V IN HUMAN MILK FOR PREVENTION OF INFECTION AND INFLAMMATION IN PRETERM NEONATES
Murdoch University Background: A clinical trial has succeeded in reducing the burden of sepsis and necrotising enterocolitis in preterm neonates by combining bovine lactoferrin (bLf ) and probiotic supplements in human milk feeds. Despite these positive clinical outcomes, there have been no in vitro quantitative studies which have evaluated the interaction of probiotics and bLf against pathogenic bacteria in human milk.
Methods: This study used both pasteurised (PDHM) and unpasteurised (UDHM) donated human milk samples from five different mothers. These samples were supplemented with bLf (5 mg/mL and 50 mg/mL) or 5 mg/mL human lactoferrin (hLf ).
The neonatal sepsis pathogens Staphylococcus epidermidis and
Escherichia coli, and the probiotic strain, Bifidobacterium breve M-16 V were individually cultured in each condition for four hours. B. breve was co-cultured with the sepsis pathogens in each condition for four hours. Each bacteria was then enumerated by a colony count method to determine the colony forming units (CFU)/mL.
Results: UDHM showed more inhibition of pathogenic bacterial growth compared to PDHM, especially E. coli (p < 0.01). This study also showed that hLf was far more effective at inhibiting bacterial growth, when compared to both 5 mg/mL and 50 mg/ mL bLf, especially when cultured in UDHM. In addition, blf supplementation negatively affected growth of B. breve in PDHM (p < 0.01).
Conclusions: Although further work needs to be performed, including in vivo studies, it appears that mother's own milk should be prioritised for preterm neonate feeds, due to UDHM and hLf showing the greatest antimicrobial activity against sepsis pathogens in this study. Preterm neonates could also benefit from probiotics and bLf interventions to be separated during feeds. Background: Refugee background women experience adverse birth outcomes, including stillbirth, more commonly than Australian born women. Refugee women are less likely to access and remain engaged with antenatal care and are dissatisfied with the care they receive. Group delivery of pregnancy care is showing promise as a model that can increase access to care, health information and social support, to lead to better maternal and child health outcomes.
IMPROVING ACCESS, EQUITY AND HEALTH LITERACY
Method: Healthy Happy Beginnings is group pregnancy care and information model for Karen Burmese women. A multidisciplinary team including a midwife, maternal and child health nurse, and bicultural worker co-facilitate group sessions. Individual antenatal appointments with a midwife and an interpreter are provided alongside group the sessions.
Results: Approximately 100 women have participated. Women who participated in the program reported that they: felt prepared for labour and childbirth; learnt key words in English; made friends; appreciated having both pregnancy visits close to their home and the continuity of maternal and child health nurse and bicultural worker after childbirth.
Conclusions: This innovative model addresses factors that are likely contributors to better maternal and child health outcomes including access and continued engagement with pregnancy care, seamless transitions between universal health systems, information shared in community language, peer support, community engagement and cultural safety. Partnership has been pivotal to this new approach to multidisciplinary, inter-agency approach to addressing contributing factors for poor perinatal health outcomes.
